Market Research Report
Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023
|Published by||MarketsandMarkets||Product code||765930|
|Published||Content info||99 Pages
Delivery time: 1-2 business days
|Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023|
|Published: January 3, 2019||Content info: 99 Pages||
"The global hemostasis valves market is projected to register a CAGR of 5.8% during the forecast period."
The market size for hemostasis valves is expected to reach 175 million by 2023 from USD 132 million in 2018, at a CAGR of 5.8%. The growth in this market is attributed to the increasing number of interventional procedures. Emerging markets will be the key growth hotspots in the hemostasis valves market; a favorable market scenario in these countries will serve to attract a number of players to focus on opportunities there.
On the basis of type, the hemostasis valves market is segmented into hemostasis valve Y-connectors, double Y-connector hemostasis valves, one-handed hemostasis valves, and other hemostasis valves. In 2018, the hemostasis valve Y-connectors segment is expected to account for the largest share of the hemostasis valves market. The increasing number of interventional procedures worldwide is a key factor driving the growth of this segment.
On the basis of application, the hemostasis valves market is segmented into two segments, namely, angiography and angioplasty. During the forecast period, the angiography segment is estimated to register the highest growth rate in the overall hemostasis valves market. This growth is mainly due to the increasing number of coronary angiography procedures. With the increasing number of angiography procedures, the demand for hemostasis valves is expected to increase during procedures.
In this report, the hemostasis valves market is segmented into four major regional segments-North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the increasing number of interventional procedures, increasing number of hospitals, and growing geriatric population.
Key players in the hemostasis valves market include: Teleflex Incorporated (US), Boston Scientific (US), Abbott (US), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (US), Freudenberg Medical (US), Argon Medical (US), and Scitech (Brazil).
The report analyzes the hemostasis valves market by type, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.